Medicare’s new RAPID coverage pathway speeds adult device access, but pediatric devices still lag

The Centers for Medicare and Medicaid Services and the FDA introduced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway. The new process promises Medicare national coverage within two months of FDA market authorization, a significant acceleration from the typical year-long wait.

Proponents say the RAPID pathway could remove a major reimbursement barrier for adult medical devices, allowing patients quicker access to innovative treatments. The author, a senior research scientist with experience guiding small companies through FDA review, welcomes the change as a needed step forward.

However, the announcement does not address the longstanding lag in pediatric and orphan device development. The author notes that children continue to face slower approval and coverage timelines, leaving a critical gap in care despite the broader regulatory improvement.

The piece calls for continued focus on pediatric device innovation to ensure that the benefits of faster coverage extend to all patient groups.